WallStSmart

Modular Medical Inc (MODD)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

SYK leads profitability with a 14.4% profit margin vs 0.0%. SYK earns a higher WallStSmart Score of 63/100 (C+).

MODD

Avoid

26

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 6.0
Piotroski: 1/9Altman Z: -12.19

SYK

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 7.5Value: 3.3Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MODD.

SYKSignificantly Overvalued (-47.2%)

Margin of Safety

-47.2%

Fair Value

$228.91

Current Price

$339.03

$110.12 premium

UndervaluedFair: $228.91Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MODD2 strengths · Avg: 10.0/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

SYK3 strengths · Avg: 8.3/10
Market CapQuality
$128.87B9/10

Large-cap with strong market position

Operating MarginProfitability
27.0%8/10

Strong operational efficiency at 27.0%

EPS GrowthGrowth
44.1%8/10

Earnings expanding 44.1% YoY

Areas to Watch

MODD4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$12.50M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

SYK3 concerns · Avg: 3.7/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

P/E RatioValuation
35.3x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : MODD

The strongest argument for MODD centers on Price/Book, Debt/Equity.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap, Operating Margin, EPS Growth.

Bear Case : MODD

The primary concerns for MODD are Revenue Growth, EPS Growth, Market Cap.

Bear Case : SYK

The primary concerns for SYK are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

SYK carries more volatility with a beta of 0.77 — expect wider price swings.

SYK is growing revenue faster at 9.4% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SYK scores higher overall (63/100 vs 26/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Modular Medical Inc

HEALTHCARE · MEDICAL DEVICES · USA

Modular Medical, Inc., a development-stage medical device company, focuses on the design, development and marketing of insulin pumps for people with insulin-dependent diabetes. The company is headquartered in San Diego, California.

Visit Website →

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?